Stabilized compositions comprising a therapeutically active agent, citric acid or a conjugated base and chlorine dioxide

Details for Australian Patent Application No. 2005253931 (hide)

Owner Allergan, Inc.

Inventors Jordan, Robert S.; Lyons, Robert T.

Agent Davies Collison Cave

Pub. Number AU-B-2005253931

PCT Pub. Number WO2005/123135

Priority 10/865,639 09.06.04 US

Filing date 19 May 2005

Wipo publication date 29 December 2005

Acceptance publication date 19 May 2011

International Classifications

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/19 (2006.01)

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123135 Priority application(s): WO2005/123135

19 May 2011 Application Accepted

  Published as AU-B-2005253931

15 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005253943-Electro-hydraulically powered lift ambulance cot

2005253930-Interfacial stent and method of maintaining patency of surgical fenestrations